EU Safety Gate · Report-2016-034
Derma Innovo · Ep-Derm
The cream and liquid contain betamethasone (0,054% and 0.044% by weight respectively), a corticosteroid that should be applied to the skin only if prescribed to treat certain skin conditions. In addition to the skin lightening effect, it can induce skin rash and burning at the application site and long-time exposure could lead to endocrine problems. The cream and liquid also contain triclosan, which is non-authorised in skin cream and tonics. The products do not comply with the Cosmetic Products Regulation.
- Published
- 26 August 2016
- Notifying authority
- Germany
- Catalog checked
- 30 July 2026
Check the authority measure and original alert.
Type of economic operator to whom the measure(s) were ordered: Other. Category of measure(s): Ban on the marketing of the product and any accompanying measures. Date of entry into force: 11/07/2016 · Type of economic operator taking notified measure(s): Importer. Category of measure(s): Warning consumers of the risks. Date of entry into force: 11/07/2016 · Type of economic operator taking notified measure(s): Importer. Category of measure(s): Recall of the product from end users. Date of entry into force: 11/07/2016
Official source alertProduct identification
- Safety Gate reference
- A12/1075/16
- Model
- Ep-Derm Creme, Ep-Derm Liquid
- Batch
- MHD Jan 2018
Classification
- Category
- Cosmetics
- Risk type
- Chemical
- Country of origin
- People's Republic of China
Product description
Ep-Derm Creme: cardboard box, accompanying leaflet, pump bottle; Ep-Derm Liquid: cardboard box, accompanying leaflet, pump bottle, plastic dropper.